RHYTHM PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
15 Contracts & Agreements
- Investment Agreements (1 contract)
- Investor Rights Agreements (2)
- Purchase Agreements (1)
- Share Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (5)
- Investment Agreement, dated as of April 1, 2024, by and among Rhythm Pharmaceuticals, Inc., and the investors named therein (Filed With SEC on April 1, 2024)
- Share Purchase Agreement, by and between Rhythm Pharmaceuticals Netherlands B.V. and Xinvento B.V., dated February 27, 2023 (Filed With SEC on March 1, 2023)
- Underwriting Agreement, dated as of September 14, 2022, between Rhythm Pharmaceuticals, Inc. and Cowen and Company, LLC, Stifel, Nicolaus & Company, Incorporated and Wells Fargo... (Filed With SEC on September 15, 2022)
- 2022 Employment Inducement Plan Form of Restricted Stock Unit Agreement (Filed With SEC on March 1, 2022)
- Amendment No. 1 to Amended and Restated Investors Rights Agreement, dated January 25, 2021 (Filed With SEC on November 2, 2021)
- Underwriting Agreement, dated as of February 4, 2021, between Rhythm Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc., Cowen and Company, LLC and Stifel,... (Filed With SEC on February 5, 2021)
- Asset Purchase Agreement, dated as of January 5, 2021, by and between Rhythm Pharmaceuticals, Inc. and Alexion Pharmaceuticals, Inc (Filed With SEC on January 5, 2021)
- Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 2, 2020)
- Underwriting Agreement dated October 15, 2019 (Filed With SEC on October 16, 2019)
- First Amendment to the 2017 Employee Stock Purchase Plan (Filed With SEC on June 18, 2018)
- Form of Underwriting Agreement (Filed With SEC on June 18, 2018)
- Rhythm Pharmaceuticals, Inc. 2017 Employee Stock Purchase Plan (Filed With SEC on November 14, 2017)
- Rhythm Pharmaceuticals, Inc. 2017 Employee Stock Purchase Plan (Filed With SEC on September 25, 2017)
- Form of Underwriting Agreement (Filed With SEC on September 25, 2017)
- Amended and Restated Investors' Rights Agreement, dated August 21, 2017, by and among the Registrant and the investors set forth therein (Filed With SEC on September 5, 2017)
